Thyrocare Technologies

Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y

Trade Spotlight: How should you trade Hubtown, Thyrocare Tech, EID Parry, JSW Infrastructure, Rallis India, Piramal Enterprises and others on July 14?

Consolidation is expected to continue in the upcoming sessions until the frontline indices trade above their short-term moving averages. Below are some short-term trading ideas to consider.

InCred adds Thyrocare to conviction list, exits Marico, Pidilite, SBI Cards

InCred Equities added Thyrocare Technologies to its conviction list while exiting Pidilite, Marico, and SBI Cards, citing shifting fundamentals and earnings outlook

Buy Thyrocare Technologies; target of Rs 1000: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1000 in its research report dated April 24, 2025.

Thyrocare Techn Consolidated March 2025 Net Sales at Rs 187.16 crore, up 21.34% Y-o-Y

Thyrocare shares skyrocket 20% after profit, revenue see double-digit growth in Q4

Thyrocare Tech reported a 21.9 percent year-on-year increase in net profit, which stood at Rs 21.7 crore in Q4

Thyrocare Techn Standalone March 2025 Net Sales at Rs 173.87 crore, up 23.11% Y-o-Y

Stocks to Watch Today: Tata Consumer Products, BPCL, Adani Green Energy, Panacea Biotec, Thyrocare, Bajaj Housing, LTIMindtree in focus on 24 April

Stocks to watch, 24 Apr: Stocks like Syngene International, Wendt India, Supreme Petrochem, 360 ONE WAM, Can Fin Homes, Rallis India, Tata Teleservices (Maharashtra), Tamilnad Mercantile Bank, Filatex India, Biocon, Niva Bupa Health Insurance Company, Spandana Sphoorty Financial, and Bajaj Finance will be in focus on April 24.

Thyrocare Techn Consolidated December 2024 Net Sales at Rs 165.92 crore, up 23.14% Y-o-Y

Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

Thyrocare reported 23% YoY rise in revenue in December quarter

Thyrocare Techn Standalone December 2024 Net Sales at Rs 152.55 crore, up 24.14% Y-o-Y

Stock Radar: Wipro, Wonderla Holidays, EPACK Durable, RVNL, Reliance Power, Kaynes Technology in focus on Wednesday

Stocks like Oil and Natural Gas Corporation, Indian Energy Exchange, Nitiraj Engineers, Kore Digital, Hero MotoCorp, PTC India, HG Infra Engineering, Thyrocare Technologies, Max Healthcare Institute, and Deepak Nitrite will also be in focus on December 4.

Thyrocare Techn Consolidated September 2024 Net Sales at Rs 177.36 crore, up 19.84% Y-o-Y

Thyrocare Techn Standalone September 2024 Net Sales at Rs 163.05 crore, up 19.63% Y-o-Y

Stock Radar: HUL, Escorts Kubota, NLC India, Nuvoco Vistas, AU SFB, VIP Industries, Thyrocare, Dr Lal PathLabs in focus on Thursday

Stocks like Sona BLW Precision Forgings, Birlasoft, Birla Corporation, Fedbank Financial Services, Karnataka Bank, MAS Financial Services, Navin Fluorine International, Schaeffler India, and Piramal Pharma will also be in focus on October 24.

Trade Spotlight: How should you trade HDFC AMC, Finolex Industries, Orient Cement, CESC, ITD Cementation and others on Thursday?

The consolidation in the market is expected to continue, with a focus on stock-specific action amid the earnings season. Below are some trading ideas for the near term.

Buy Thyrocare Technologies; target of Rs 825: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 825 in its research report dated July 24, 2024.

Thyrocare Techn Consolidated June 2024 Net Sales at Rs 156.91 crore, up 16.32% Y-o-Y

Thyrocare Techn Standalone June 2024 Net Sales at Rs 143.63 crore, up 16.2% Y-o-Y

Stock Radar: HUL, Bajaj Finance, Torrent Pharma, Parag Milk, Vedanta in focus on Wednesday

United Spirits, ICICI Prudential Life Insurance Company, DCM Shriram, Schaeffler India, Thyrocare Technologies, Dr Reddy’s Laboratories, and Tata Consumer Products will also be in focus on Wednesday.

Buy Thyrocare Technologies; target of Rs 750: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 15, 2024.

Thyrocare Techn Standalone March 2024 Net Sales at Rs 141.23 crore, up 13.15% Y-o-Y

Thyrocare Techn Consolidated March 2024 Net Sales at Rs 154.25 crore, up 13.52% Y-o-Y

Thyrocare Techn Consolidated December 2023 Net Sales at Rs 134.74 crore, up 5.24% Y-o-Y

Thyrocare Techn Standalone December 2023 Net Sales at Rs 122.89 crore, up 4.88% Y-o-Y